Smofkabiven Peripheral 210 mg (Lysine (Lysine Acetate) EMULSION) 210 MG

SMOFKABIVEN Peripheral 210 mg is an intravenous emulsion containing lysine (lysine acetate). It is designed to provide essential amino acids for nutritional support. This product is manufactured by Fresenius Kabi Canada Ltd.

Strength

210 MG

Pack Size

4X1206/4X1448/4X1904ML

Manufacturer / TM Owner

FRESENIUS KABI CANADA LTD

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

SMOFKABIVEN Peripheral 210 mg is used for nutritional support in patients who cannot consume food orally. It provides essential amino acids, including lysine, which are crucial for various bodily functions. This emulsion is often used in clinical settings to support patients' nutritional needs during intravenous therapy.

Side Effects

The effects of SMOFKABIVEN Peripheral 210 mg include providing essential amino acids to the body. These amino acids are vital for protein synthesis, tissue repair, and overall nutritional health. The emulsion is designed to be well-tolerated when administered intravenously.

Precautions & Warnings

SMOFKABIVEN Peripheral 210 mg should be handled with care and administered under medical supervision. It is important to follow proper storage and handling guidelines to maintain the integrity of the emulsion. Patients should be monitored for any adverse reactions during administration.

Avoid Interactions

SMOFKABIVEN Peripheral 210 mg may interact with other medications or supplements. It is important to inform healthcare providers about all current medications to avoid potential interactions. Always consult a healthcare professional before starting any new treatment.

Frequently Asked Questions

SMOFKABIVEN Peripheral 210 mg is used for nutritional support in patients who cannot consume food orally. It provides essential amino acids, including lysine, which are crucial for various bodily functions.

SMOFKABIVEN Peripheral 210 mg is administered intravenously. It should be handled and administered under medical supervision.

The common effects include providing essential amino acids to the body, which are vital for protein synthesis, tissue repair, and overall nutritional health.

Yes, it should be handled with care and administered under medical supervision. Proper storage and handling guidelines should be followed to maintain the integrity of the emulsion.

Yes, it may interact with other medications or supplements. It is important to inform healthcare providers about all current medications to avoid potential interactions.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.